204 related articles for article (PubMed ID: 22191650)
1. Recent advances in copper radiopharmaceuticals.
Hao G; Singh AN; Oz OK; Sun X
Curr Radiopharm; 2011 Apr; 4(2):109-21. PubMed ID: 22191650
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
Shokeen M; Anderson CJ
Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in
Krasnovskaya OO; Abramchuck D; Erofeev A; Gorelkin P; Kuznetsov A; Shemukhin A; Beloglazkina EK
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298101
[TBL] [Abstract][Full Text] [Related]
4. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.
Anderson CJ; Ferdani R
Cancer Biother Radiopharm; 2009 Aug; 24(4):379-93. PubMed ID: 19694573
[TBL] [Abstract][Full Text] [Related]
5. Reactor produced [
Chakravarty R; Shetty P; Nair KVV; Rajeswari A; Jagadeesan KC; Sarma HD; Rangarajan V; Krishnatry R; Chakraborty S
Ann Nucl Med; 2020 Dec; 34(12):899-910. PubMed ID: 33048309
[TBL] [Abstract][Full Text] [Related]
6. Copper chelation chemistry and its role in copper radiopharmaceuticals.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Curr Pharm Des; 2007; 13(1):3-16. PubMed ID: 17266585
[TBL] [Abstract][Full Text] [Related]
7. A comparison of PET imaging characteristics of various copper radioisotopes.
Williams HA; Robinson S; Julyan P; Zweit J; Hastings D
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1473-80. PubMed ID: 16258764
[TBL] [Abstract][Full Text] [Related]
8. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
Li F; Jiang S; Zu Y; Lee DY; Li Z
J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
[TBL] [Abstract][Full Text] [Related]
10. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging.
Pasquali M; Martini P; Shahi A; Jalilian AR; Osso JA; Boschi A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):371-381. PubMed ID: 33026209
[TBL] [Abstract][Full Text] [Related]
11. Alternative routes for
Dellepiane G; Casolaro P; Mateu I; Scampoli P; Braccini S
Appl Radiat Isot; 2023 Jan; 191():110518. PubMed ID: 36327610
[TBL] [Abstract][Full Text] [Related]
12. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
[TBL] [Abstract][Full Text] [Related]
13. Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.
Xie Q; Zhu H; Wang F; Meng X; Ren Q; Xia C; Yang Z
Molecules; 2017 Apr; 22(4):. PubMed ID: 28420176
[TBL] [Abstract][Full Text] [Related]
14. Coordination Chemistry of Bifunctional Chemical Agents Designed for Applications in
Sharma AK; Schultz JW; Prior JT; Rath NP; Mirica LM
Inorg Chem; 2017 Nov; 56(22):13801-13814. PubMed ID: 29112419
[TBL] [Abstract][Full Text] [Related]
15. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.
Cai Z; Anderson CJ
J Labelled Comp Radiopharm; 2014 Apr; 57(4):224-30. PubMed ID: 24347474
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands.
Sun X; Kim J; Martell AE; Welch MJ; Anderson CJ
Nucl Med Biol; 2004 Nov; 31(8):1051-9. PubMed ID: 15607487
[TBL] [Abstract][Full Text] [Related]
17. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
18. Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis.
Earley DF; Esteban Flores J; Guillou A; Holland JP
Dalton Trans; 2022 Mar; 51(13):5041-5052. PubMed ID: 35285835
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging of poststroke angiogenesis.
Cai W; Guzman R; Hsu AR; Wang H; Chen K; Sun G; Gera A; Choi R; Bliss T; He L; Li ZB; Maag AL; Hori N; Zhao H; Moseley M; Steinberg GK; Chen X
Stroke; 2009 Jan; 40(1):270-7. PubMed ID: 18948613
[TBL] [Abstract][Full Text] [Related]
20. PET with non-standard nuclides.
Hao G; Singh AN; Liu W; Sun X
Curr Top Med Chem; 2010; 10(11):1096-112. PubMed ID: 20388114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
